Ceftaroline

Paul A. Pham, Pharm.D. BCPS
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Acute bacterial skin and skin structure infections (ABSSSIs)
    • Due to susceptible organisms: S. aureus(including MRSA), S. pyogenes, S. agalactiae, E.coli, K. pneumoniae, K. oxytoca.
  • Community acquired pneumonia (including cases caused by PCN-resistant S. pneumoniae)
    • Due to susceptible organisms: S. pneumoniae (including cases with bacteremia), MSSA, H. influenzae, K. pneumoniae, E. coli

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • MRSA infections not listed above

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.